6505--Bevacizumab Injection
ID: 36E79725R0019Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e10445b3a18a4fcab57f519ce36489be/view
Timeline
    Description

    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.

    Point(s) of Contact
    Matthew PoulinContract Specialist
    (708) 786-5186
    Matthew.Poulin@va.gov
    Files
    Title
    Posted
    36E79725R0019_1.docx
    The presolicitation notice issued by the Department of Veterans Affairs pertains to the procurement of Bevacizumab Injection (Product Service Code 6505, NAICS Code 325412). The notice includes essential details such as the solicitation number (36E79725R0019), response deadline scheduled for March 4, 2025, at 2:30 PM Central Time, and archival information specifying that documents will be archived 99 days post-response. The contracting office is located at Building 37, Hines, IL 60141, with the designated point of contact being Contract Specialist Matthew Poulin, available at 708-786-5186 or via email at Matthew.Poulin@va.gov. The notice highlights the procedural aspects of the procurement process and lays the groundwork for bidding on this essential pharmaceutical product, which serves the healthcare needs of veterans. Overall, it reflects the government's commitment to ensuring the availability of critical medications through structured procurement practices.
    Lifecycle
    Title
    Type
    6505--Bevacizumab Injection
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--770-25-1-801-0073 - National CMOP D0286 DORZOLAMIDE -(VA-25-00021409) (VA-25-00021409)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of dorzolamide hydrochloride ophthalmic solution under the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The primary objective is to acquire this pharmaceutical product in various quantities, ensuring compliance with specific contract terms, delivery standards, and regulatory requirements, including adherence to the Drug Supply Chain Security Act (DSCSA). This procurement is crucial for maintaining the quality and availability of essential medications for veterans' healthcare needs. Interested vendors must submit their quotes by January 30, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further information.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    Q522--Contrast Injector Service Contract
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a service contract to maintain and support Bayer MedRad contrast injectors at the Baltimore VA Medical Center. The contract will cover a base year from February 12, 2025, to February 11, 2026, with two optional renewal years, and requires vendors to provide comprehensive maintenance services, including repairs, preventative maintenance, software updates, and technical support to ensure compliance with OEM specifications. This initiative is critical for maintaining the operational reliability of medical equipment, which is essential for patient care at the facility. Interested vendors should contact Contracting Officer Keysha Gorman at Keysha.Gorman74@va.gov for further details and to submit proposals in accordance with the outlined requirements.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    Prescription-fill services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VISN 15 Network Contracting Office, is seeking qualified contractors to provide prescription-fill services for eligible veterans at the Harry S. Truman Memorial Veterans’ Hospital (HSTMVH) and its associated community-based outpatient clinics (CBOCs) and Home Based Primary Care (HBPC) program, starting June 1, 2025. The contractor will be responsible for filling and dispensing medications, offering patient counseling, and ensuring compliance with Joint Commission standards while maintaining operations during specified hours. This initiative is crucial for enhancing access to pharmacy services for veterans, thereby prioritizing their health and medication management. Interested parties must submit their responses, including company information and capabilities, to Steve Parrott at stephen.parrott@va.gov by February 7, 2025, at 10:00 AM CST, as this is a Request for Information (RFI) and not a solicitation.